regenerative medicine


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.
A nascent field of ‘bleeding edge’—a term of art meaning really advanced—medicine described as the creation of tissues that provide, repair, replace or restore structures and functions absent or lost due to congenital defects, ageing, disease, or damage

regenerative medicine

The use of stem cells to treat diseases caused by the loss or degeneration of cells in vital organs such as the brain, heart, or kidneys.
Synonym: reparative medicine (1)
See also: medicine
References in periodicals archive ?
Sixty percent of the regenerative medicine market focuses on cell therapy; with its primary focus on stem cell therapy.
Globally, there are over companies focused on regenerative medicine.
Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines, which are palliative.
To establish and maintain technology platform involving regenerative medicine and cell therapy taking advantage of multi-functional characteristics of cells in order to realize higher efficacy of treatment that cannot be achieved by existing therapy.
While the principles of regenerative medicine are easy to explain and the possible benefits even easier to appraise, relatively few products have made it into clinical trials, and even fewer into therapy.
Thayer says he will seek out a place on the board of directors for the Regenerative Medicine Research Institute and Tissue Bank.
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals.
Regenerative medicine has also been an area of interest for major pharma companies, many of which have set up their own R & D units or have acquired stakes / invested in regenerative medicine companies.
Japan s only company dealing with regenerative medical products, to promote the project for practical application of regenerative medicine in China and Thailand , one of the projects adopted under the Ministry of Economy, Trade and Industry s feasibility research on the overseas deployment of Japanese medical devices and services .
However, these challenges will be overcome by the maturing market, investment from pharmaceutical companies and the creation of regenerative medicine centres.
Details of the achievement will be presented at the 5th Annual Congress of the Japanese Society for Regenerative Medicine.
After decades of research, many regenerative medicine technologies are in development and approaching commercialization stage, thus leading to the creation of a revenue generating industry.